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Abstract
Background: The burden of imported malaria is predominantly in travellers visiting friends and relatives (VFR) in
sub-Saharan Africa. The failure of this group to use chemoprophylaxis is recognized as the most important risk
factor for the high incidence of disease. Understanding the reasons for failure to follow national recommendations
may relate to knowledge, risk perception, cost, and peer pressure. Research into these variables is critical to understand
and change practices in this group and this study was designed to explore whether knowledge, risk perception and
prophylaxis use differs between travellers’ to various destinations and the rest of the UK population.
Methods: Two face-to-face questionnaire surveys were conducted to collect information on demographics, malaria
knowledge, source, and quality of pre-travel advice, past travel experience and perceived malaria threat. One was an
IPSOS survey of individuals representative of the UK population. The other was a departure lounge survey (Civil Aviation
Authority (CAA)) of passengers departing to malarious regions detailing destinations and use of chemoprophylaxis.
Results: Around a quarter of the 1,991 UK population surveyed had previously travelled to a malarious area.
Five-hundred departing passengers were interviewed, of which 80% travelled for leisure (56% VFR’s) and 42%
were travelling to West Africa. Malaria knowledge among the UK population (score 58.6) was significantly lower
than that of individuals who had previously travelled or were travelling (63.8 and 70.7 respectively). Malaria
knowledge was similar in individuals who had and had not sought pre-travel advice and travellers using and not
using chemoprophylaxis for their journey. Leisure travellers to Ghana and Nigeria were predominantly VFRs
(74%), whilst 66% of travellers to Kenya were tourists. Despite similar high knowledge scores and perceived
(>90%) threat of the lethality of malaria in the three groups, chemoprophylaxis use in Nigerians (50%) was substantialy
lower than in passengers departing to Kenya (78%) and Ghana (82%). More frequent annual return visits were made to
Nigeria (72%) than to Ghana (38%) or Kenya (23%).
Conclusion: Travellers had more malaria knowledge than the non-travelled UK population. Malaria knowledge,
perceived threat, travel experience, and quality of pre-travel advice appear unrelated to the use of chemoprophylaxis in
passengers. Reducing malaria in VFR travellers will require strategies other than improving malaria knowledge and
enhancing malaria risk awareness.
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Malaria is an important infectious disease: the World
Health Organization (WHO) estimates 219 million cases of
malaria (range 154–289 million) and 660,000 deaths (range
610,000-971,000) in 2010 [1]. Worldwide travel, exposing
travellers from non-endemic regions to malaria-endemic
countries, is an ongoing source of imported malaria. In the
UK approximately 1,500 cases are imported annually of
which 76% are Plasmodium falciparum malaria and the
majority (64.5%) of imported cases are acquired by travel-
lers visiting friends and relatives (VFRs), and around half
(54%) is acquired during travel to either Ghana or Nigeria
of whom only 7% use malaria preventative measures [2].
Understanding why the currently very effective, available
measures are not used by high-risk travellers is fundamen-
tal to reducing the burden of imported disease. The chal-
lenge of studying knowledge, attitudes and practices
(KAP) of travellers is in capturing the information from
an unbiased and representative population, and not rely-
ing on data from those seeking pre-travel health advice or
questioning patients having developed malaria after travel-
ling. Some studies have focussed on high-risk VFR travel-
lers. Pistone and colleagues assessed the KAP of VFRs
around malaria transmission but these were recruited in
travel clinics [3], and Leonard and Van Landingham ex-
plored practices using discussion groups of Nigerians who
had previously travelled to Nigeria and were recruited
from a community in Houston, USA [4]. Schilthuis [5]
interviewed West African immigrants, from countries
including Nigeria and Ghana, living in the Netherlands
who were recruited from a community through churches
and local societies. Van Genderen and colleagues explored
changing KAP in departing passengers from Schiphol Air-
port between 2002 and 2009 to understand educational
needs for Dutch travellers on malaria [6].
This study was designed to investigate the knowledge
and practices of a representative sample of the population
by interviewing 2,007 of the UK population of which 1991
were completed. A similar tool was used to question pas-
sengers in departure lounges at Heathrow Airport whose
destination was a malaria-endemic country. This would
allow a comparison of the knowledge and practices of the
two populations and understand what factors might influ-
ence knowledge, including variables such as previous travel
experience and sources of pre-travel information and demo-
graphics (age, income and reason for travel). The departure
lounge survey also allowed for interviewing an unbiased
travelling population to malaria-risk regions from which to
identify the proportion of travellers using chemoprophylaxis.
Methods
UK population sampling
Adults aged 15 years or more were interviewed at home
using IPSOS Mori’s Capibus survey during a five-day period
at the end of May 2011. This uses a two-stage method,
the primary sampling units (PSU) being amalgamations
of the 2001 UK Census Output Areas, each of which has
approximately 125 addresses. The primary sampling
units are randomly selected and within them randomly
selected secondary sampling units are contiguous zones
made up of Output Areas, usually two of them. This yields
a random sample of 2,007 anonymous respondents, repre-
sentative of the population at a national and regional level.
The standard tool was supplemented by a malaria-
specific questionnaire covering knowledge of transmission,
clinical features, severity and outcomes, and methods of
prevention. Information on past travel and malaria desti-
nations and willingness to pay for malaria prevention was
also captured.
Airport departure lounge sampling was undertaken
by trained interviewers through a face-to-face survey
conducted by the Civil Aviation Authority (CAA). Five-
hundred British nationals travelling to sub-Saharan Africa
or other malaria-endemic countries, as defined in the
UK’s Advisory committee on Malaria Prevention (ACMP)
guidelines [7], were interviewed prior to boarding their
flight between June and August 2011. A multistage sam-
pling design was employed on those who were randomly
selected for interview and completed an anonymous
CAA passenger questionnaire [8] with added questions
on malaria, similar to those used in the IPSOS survey,
supplemented with additional information on chemo-
prophylaxis use for the journey, source(s) of pre-travel
health advice and household income.
Analysis
The data were cleaned and imported into R where
descriptive tables were created. Analysis of the IPSOS data
used the survey weights provided. For each of the two
surveys, a malaria knowledge score was based on four
questions relating to the mode of transmission, symptoms,
severity, and curability of malaria. For the first two ques-
tions, multiple options were offered and negative points
were assigned for incorrect answers. For the other two
questions, a single option was chosen from a list, each op-
tion being assigned zero or a positive number of points.
The score for each question was scaled to 25, resulting in
a maximum knowledge score of 100.
Sources of pre-travel advice were categorized according
to whether this was from a health source, non-health
source (internet or friend) or no pre-travel advice. Within
each survey, differences in knowledge score were calculated
between subgroups. This was done using parametric
methods (t test and regression) because initial comparisons
with bootstrap gave very similar results, suggesting that
they were sufficiently robust. Where 95% confidence inter-
vals for a difference overlapped between the two surveys,
a meta-analysis combined estimate was also calculated [9].
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The IPSOS Mori survey interviewed 2,007 individuals on
28 and 29 May 2011, selected as a representative sample
of the UK general population; 1,991 interviews were
completed and included for further analysis. Of these,
548 had previously visited a malaria-endemic country
and were analysed as a separate group. The CAA survey
included 499 departing passengers to malaria-endemic
countries, with some data missing on ethnicity and reason
for travel.
The age, gender, socio-economic class and household
income are presented in Table 1.
The study compared the CAA survey group to the UK
population IPSOS-MORI group who had, in the past,
visited a malaria-endemic country and found a larger
proportion of the CAA group visiting West Africa (42 vs
16%). Other variables, including reason for travel and
chemoprophylaxis use, were of similar proportions in
the two groups. There was a larger proportion of ethnically
black (39 vs 4%) travellers interviewed in the CAA survey
(Table 2). In the IPSOS survey, the malaria knowledge score
in those who had travelled was 63.8 (Table 2), while the
scores in those who had not travelled were more than five
points lower at 58.6 (95% CI for the difference is 3.9-6.5,
p<0.001).
The quality of pre-travel advice in the population who
had travelled previously (IPSOS survey) and those who
were about to depart (CAA survey) was similar, with
over 70% having received professional advice and 18 and
24% not seeking/received pre-travel advice (Table 2). In
the subgroup analysis of visitors to Ghana, Nigeria and
Kenya, 22, 40 and 23% of travellers, respectively, had not
sought or received advice, or used non-professional pre-
travel advice for the current trip (Table 3).
Knowledge in travellers using chemoprophylaxis was
very similar to those not using chemoprophylaxis in
both the CAA and IPSOS surveys although the IPSOS
survey group had a lower average knowledge score, with
West Africans having significantly higher scores than
other Africans and Asian travellers (Table 4). Comparing
the knowledge scores of those who had received profes-
sional pre-travel advice with those who were self-informed
or those who received no advice, the scores were almost
the same. This finding was replicated in the IPSOS survey.
Ethnicity provided a mixed picture, with the IPSOS survey
respondents having lower knowledge levels than the CAA
survey respondents and with Asians in the CAA scoring
highest (81) while the mixed and other ethnic groups in
the IPSOS survey scored lowest (57). Knowledge scores
were not influenced by reason for travel or household
income.
The use of chemoprophylaxis in passengers travelling to
malaria-endemic countries in all or part of their destination
was collected. Of the passengers departing to Kenya (132),
Nigeria (86) and Ghana (81), (71%, 38% and 74%) respect-
ively, reported taking an effective chemoprophylaxis for
their travel (Table 3). Examining the chemoprophylaxis
regimens being taken, 57% of travellers to Kenya, 37% to
Table 1 Demographic and descriptive information
CAA
a IPSOS
b
Complete survey group Travelled to malaria-endemic area
Gender, n male:female (%) 264:235 (53:47) 996:995 (48:52) 291:257 (52:48)
Age in years: mean (SD)
c 15-24 126 (25) 311 (16) 56 (9)
25-34 96 (19) 294 (16) 92 (18)
35-44 88 (18) 312 (18) 109 (24)
45-54 92 (19) 305 (16) 90 (17)
55-64 65 (13) 322 (14) 90 (15)
≥65 27 (5) 434 (20) 109 (18)
Socioeconomic group: n (%)
d A 31 (7) 69 (4) 38 (8)
B 121 (27) 383 (23) 158 (34)
C1 215 (47) 696 (29) 200 (29)
C2 53 (12) 387 (21) 81 (16)
D 28 (6) 266 (15) 47 (9)
E 6 (1) 190 (8) 24 (3)
Annual income (£, median class)
e 28,750-34,499 25,000-29,999 30,000-39,999
Total 499 1991 548
a1 person with destination Madrid is excluded from all analysis.
bThe means, medians, standard deviations and percentages in the IPSOS data are calculated using the sample weights.
Numbers of missing values in the two surveys:
c5 & 13 (for the latter, age group was recorded but not numeric age);
d45 & 0;
e100 & 724.
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quone and proguanil. The mean knowledge score in those
using chemoprophylaxis was 69 for all three destinations.
This was lower than knowledge scores in those using no
chemoprophylaxis.
Discussion
Understanding the knowledge and risk perception that
individuals have of malaria is valuable when trying to
understand attitudes and practices in the use of pre-
ventative measures. The study surveyed the UK general
population to provide a background level of knowledge
and attitudes and used the population who had previously
travelled to a malaria-endemic region (28%, 548) as a
comparator with a similarly sized departing passenger
population of 500. The average malaria knowledge score
of the general UK population who had not travelled to a
malaria-endemic country, at 58.6, was significantly lower
than in those who had previously travelled or who were
travelling (63.8 and 70.7, respectively).
Knowledge, perception of malaria and its threat, and
the use of chemoprophylaxis in departing passengers
were assessed to determine possible influences on use of
chemoprophylaxis. The main focus was on VFR’sw h ow e r e
travelling to sub-Saharan Africa, as this is the group with
the highest morbidity from malaria. The ages in the three
groups were similar but black travellers and West Africa as
ad e s t i n a t i o n ,w e r em o r ef r e q u e n ti nt h eC A Ag r o u p ,a s
this was a destination targeted by the CAA surveyors. The
source of pre-travel advice among CAA and IPSOS was
similar (72 vs 74%) received advice from a professional
source). Unexpectedly, the levels of knowledge in passen-
gers using chemoprophylaxis were lower to those not using
a drug regimen. Similarly, those travellers who had received
professional pre-travel advice did not have a higher know-
ledge score than travellers who had not received advice or
received advice through a non-professional source. The
same phenomenon was noted in the non-travelling popu-
lation, who overall, achieved lower knowledge scores.
Comparing travellers to three destinations in sub-Saharan
Africa (Table 3), passengers to Kenya were predominantly
(83%) travelling for leisure. The majority of leisure travellers
to Ghana and Nigeria were VFRs (74%) while only one
third of those travelling to Kenya were VFRs. The mean
knowledge score in those using chemoprophylaxis was 69
for the three destinations and higher (77.5, 74.2 and 74.1)
in those not using chemoprophylaxis. The perception of
threat from malaria was similar in the three groups travel-
ling, with 38% of passengers to Ghana, 46% to Nigeria and
51% to Kenya believing malaria often killed.
When asked about use of chemoprophylaxis, the majority
of passengers to Ghana (74%) and Kenya (71%) were taking
an effective regimen. However, among passengers to
Nigeria, which included 32% travelling on business, only
50% were using any chemoprophylaxis and only 38%
used an effective regimen. Despite having similar levels of
knowledge and equal understanding of the seriousness of
malaria, significantly fewer Nigerians were using preventa-
tive drugs for malaria than other destination passengers.
There is some evidence that as an alternative to chemo-
prophylaxis, some VFR travellers choose to self-treat their
fever symptoms with anti-malarial drugs either purchased
before or during travel [10,11]. This practice of self-
treatment is not recommended in the UK national
guidelines for travel to high risk regions in sub-Saharan
Africa, but may be adopted by semi-immune travellers
as an alternative to taking chemoprophylaxis. Nigerians
travelled more frequently than passengers to Kenya and
Ghana with 72% having made one or more trips to Nigeria
Table 2 Travellers description, itinerary, knowledge
prophylaxis use, and source of advice
CAA IPSOS
a
Region to which travelled: n (%)
b
West Africa 208 (42) 95 (16)
South and East Africa 199 (40) 196 (38)
Asia and other 92 (18) 397 (74)
Reason for travel: n (%)
c
Business 98 (20) 95 (18)
Leisure 397 (80) 458 (84)
of which
d: Visiting Friends & Relatives 128 (56) 185 (27)
other leisure 100 (44) 277 (57)
Prophylaxis: n (%)
e
Yes 283 (61) 302 (57)
No 181 (39) 246 (43)
Knowledge Score (mean & SD)
f 70.7 (14) 63.8 (12)
Advice Score: n (%)
none 121 (24) 113 (18)
non-professional 20 (4) 34 (7)
professional 358 (72) 401 (74)
Ethnicity: n (%)
g
White 75 (51) 393 (82)
Black 57 (39) 33 (4)
Asian 12 (8) 107 (13)
Mixed and other 3 (2) 14 (2)
Total 499 548
aRestricted to the 548 reporting previous travel to malaria-endemic countries.
The means, standard deviations and percentages are calculated using the
sample weights. Percentages may sum to more than 100 due to multiple trips.
b5 people in the IPSOS survey did not remember to which malaria-endemic
country they had travelled
Numbers of missing values in the two surveys:
c 4&3 ,
e35 & 0,
g4&0 ,
g352 & 1
dIn the CAA survey, “Migration” (n = 2) and “Studies private/grants -formal
academic course” (n=16) were classified as leisure. This is retained here because
follow-on questions were asked on the basis of this classification. For consistency,
in IPSOS, ‘live there’ (n= 4) was classified as leisure. There was no education option
in IPSOS. In CAA, only 228 of 398 respondents had data on type of leisure
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Ghana
N=8 1
Difference or regression
coefficient(95% CI)
Nigeria
N=86
Difference or regression
coefficient(95% CI)
Kenya
N= 132
Difference
(95% CI)
Reason for Travel, n (%)
a
Business 14 (18) 27 (32) 22 (17)
Leisure 66 (82) 58 (68) 109 (83)
Of which
b: VFR 31 (74) 39 (74) 23 (34)
Other leisure 11 (26) 14 (26) 44 (66)
Knowledge score (mean) by reason
Business 74.5 70.8 72.9
Leisure 70.4 −4.1 (−15, 6.7) 71.7 0.9 (−6.2, 8.0) 69.8 −3.0 (−9.4, 3.4)
Perceived fatality threat of malaria
c
Never kills 0 (0) 2 (2) 0 (0)
Occasionally kills 44 (56) 38 (48) 61 (47)
Often kills 30 (38) 37 (46) 66 (51)
Always kills 5 (6) 3 (4) 3 (2)
Number of trips over the last
12 months on this route
d
0 47 (63) 23 (28) 100 (77)
1 or 2 14 (19) 26 (32) 18 (14)
≥3 14 (19) 32 (40) 12 (9)
Chemoprophylaxis regimen, n (%)
Any prophylaxis
e 62 (82) 38 (50) 98 (78)
Of which
Doxycycline (daily) 14 (18) 4 (5) 19 (15)
Mefloquine(weekly) 17 (22) 4 (5) 2 (2)
Atovaquone/proguanil (daily) 28 (37) 24 (32) 72 (57)
Chloroquine (weekly) 2 (3) 6 (8) 0 (0)
Other 1 (1) 0 (0) 5 (4)
Knowledge score by prophylaxis use (mean)
Prophylaxis not used 77.5 74.2 74.1
Prophylaxis used 69.8 −7.7 (−18, 2.9) 69.3 −4.9 (−12, 2.0) 69.1 −5.0 (−11, 0.8)
Change in knowledge
score per doubling in income
−1.41 (−3.62, 0.79) 0.65 (−1.29, 2.60) −0.31 (−1.92, 1.3)
Advice obtained by prophylaxis use
No prophylaxis, n (%)
None, or non-professional 13 (93) 27 (71) 16 (57)
Professional 1 (7) 11 (29) 12 (43)
Prophylaxis, n (%)
None, or non-professional 4 (6) 5 (13) 10 (10)
Professional 58 (94) 33 (87) 88 (90)
All travellers by advice
None, or non-professional
f 18 (22) 34 (40) 30 (23)
Professional 63 (78) 52 (60)
g 102 (77)
h
a1 missing value for each country; missing values excluded from denominator of percentages in this & other rows.
bN without information on type of leisure, by country: 24, 5 & 42.
cN missing by country: 2, 6 & 2.
dN missing by country: 6, 5 & 2.
eN missing 5, 10 & 6.
fThese two categories were merged due to small numbers in the latter.
g17% less than Ghana, 95% CI 2–32, p= 0.02.
h0.5% less than Ghana, 95% CI 12–13, p= 1.
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not received professional pre-travel advice before the
current journey, nearly double that of visitors to Ghana
(22%) and Kenya (23%).
The proportion of travellers accessing health care
pre-travel in this study represents an unbiased sample
of departing travellers and their prophylaxis use. Many
other studies of malaria prophylaxis compliance have been
based on travellers with malaria or travellers departing
from endemic countries [10,12] although some have ques-
tioned departure lounge passengers [13].
The study’s assessment of knowledge was based around
a range of 22 questions that had weighted responses. It
is possible that questions may not have been probing
or detailed enough or the weighting not adjusted to
provide the sensitivity to define knowledge accurately.
The sample sizes of travellers to sub-Saharan regions were
large enough for sub-analysis but there were a number
of other countries visited in Southeast Asia, the Indian
Subcontinent and South America whose numbers were
too small to analyse separately.
These findings suggest that malaria knowledge, perceived
threat, previous travel experience and source (quality) of
pre-travel advice are not important factors in predicting
the use of chemoprophylaxis. Failure to obtain pre-travel
advice may still be a contributory factor to non-use of
chemoprophylaxis but not linked to knowledge of malaria
or threat perception, (belief that malaria occasionally, often
or always kills) which was similar in the three groups.
Repeated travel to Nigeria was strikingly more frequent
and may be an important influence in reducing chemo-
prophylaxis use.
In a European-wide departure survey of travellers to
high-risk malaria regions, 56% were carrying malaria
prophylaxis and 28% carried self-treatment for malaria
[14]. In this survey 52.1% had received pre-travel advice
although only 31.4% of VFRs had received advice. The
majority of advice (80%) was from a health professional
with one-quarter of respondents obtaining advice from
the internet and/or friends [14]. A Spanish departure sur-
vey reported that 64% of travellers to sub-Saharan Africa
were using chemoprophylaxis. Over 83% of respondents
had sought pre-travel advice and travellers who had visited
the same region previously were three times less likely to
seek health information than first-time travellers [15].
Schilthuis interviewed Nigerians and Ghanaians living in
the Netherlands and reported that only 16% of the VFRs
had adequate knowledge of malaria [5]. Departing Dutch
Table 4 Knowledge score in subgroups of the two surveys
CAA IPSOS IPSOS v CAA
Variable Mean
know-ledge
score
Difference in
means, or
regression
coefficient
95% CI
within
variable
Weighted mean
knowledge
score
Difference in
means, or
regression
coefficient
95% CI
within
variable
Overall
estimate
&C I
a
Prophylaxis No 71.7 62.5
Yes 70.0 −1.7 (−4.30, 0.98) 64.7 2.3 (0.22, 4.35) 0.79 (−0.83, 2.41)
Advice score None 72.8 61.9
Non-professional 70.5 62.8
Professional 70.0 −2.7 (−5.61, 0.26) 64.3 2.4 (−0.13, 4.97) 0.23 (−1.69, 2.15)
Ethnicity White 70.2 64.2
Black 73.4 3.1 (−1.13, 7.42) 66.1 2.5 (−2.87, 7.76) 2.87 (−0.44, 6.18)
Asian 80.8 10.6 (3.04, 18.20) 61.1 −2.6 (−5.57, 0.41) (−)
Mixed & other 76.7 6.4 (−7.89, 20.80) 56.6 −7.6 (−15.1, -0.05) −4.51 (−11.2, 2.13)
Region to which
travelled
b
West Africa 72.3 68.1
South and
East Africa
70.1 −2.3 (−5.03, 0.52) 62.6 −5.5 (−10.4, -0.56) −3.04 (−5.45, -0.62)
Asia and other 68.5 −3.8 (−7.37, -0.34) 63.3 −4.8 (−9.34, -0.27) −4.21 (−6.97, -1.44)
Reason
for Travel
Business 72.5 63.5
Leisure 70.1 −2.4 (−5.60, 0.73) 63.8 0.3 (−2.77, 2.24) −0.77 (−2.72, 1.18)
Income (per doubling) 0.34 (−0.41, 1.10) 0.02 (−0.78, 0.81) 0.19 (−0.36, 0.73)
Estimates whose 95% confidence exclude the null value, equivalent to p< 0.05, are shown in bold italics.
aMeta-analysis combination of the estimates from the two surveys. This was not done (shown ‘-’) if the two 95% confidence intervals did not overlap.
bIAll CAA participants are included. In the IPSOS survey, only those who had travelled to a single region were included here (N = 424).
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on pre-travel preparation and u s eo fa n t i - m a l a r i am e a s u r e s
and malaria knowledge; 74% had correct malaria know-
ledge, a similarly high knowledge score (71) as in this
study’s travellers from Heathrow. Dutch passengers’ use of
anti-malaria measures was overall lower (31.9%) than that
reported by all UK departing passengers (61%) and
matched the proportion of Nigerian travellers ‘use of an
effective chemoprophylaxis (38%), although the assessment
of prophylaxis usage was defined differently across the two
studies, and findings may not bed i r e c t l yc o m p a r a b l e .T h e s e
two studies highlight that malaria knowledge and risk
awareness combined with receipt of pre-travel advice
does not necessarily result in compliance with malaria
preventative measures.
Neave and colleagues [10] highlighted this paradox, where
for many VFRs the actual malaria risk did not correlate
to personal perceived risk of developing malaria, and
suggested that chemoprophylaxis use is influenced by
perceived susceptibility, previous experience of malaria,
cost of chemoprophylaxis, threat of fatality from malaria
and peer pressure [16]. This study finds that perception
of fatality from malaria does not correlate with uptake, as
Nigerians and Ghanaians have the same perceived threat
but very different chemoprophylaxis use. Cost of chemo-
prophylaxis has been argued as a major barrier to prophy-
laxis uptake, but recent evidence from two London
communities is that, despite availability of free chemo-
prophylaxis for travellers, there was marginal reduction
in imported malaria in VFR travellers when compared to a
non-subsidized community [17].
Conclusion
Reducing malaria in high-risk VFR travellers will require
other strategies than relying on improving malaria know-
ledge and enhancing malaria risk awareness. Future strat-
egies that may improve malaria protection might include
rapid access to diagnosis with rapid diagnostic tests and
artemisinin combination treatment in London primary care
practices which would be more rapidly accessible than
tertiary care diagnostics and in-patient treatment. A more
radical solution could be to selectively provide diagnostic
and self-treatment kits to semi-immune adults who should
be capable of undertaking their own testing. Such a
policy would however be difficult to implement in par-
allel with the current policy, which promotes the use of
chemoprophylaxis.
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